ClinicalTrials.gg
RecruitingNCT06654141Updated Feb 19, 2025

Influence of Healing Time on the Outcomes of Alveolar Ridge Preservation in Periodontally Compromised Extraction Sockets

An interventional study of Alveolar ridge preservation in Tooth Loss, sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to histologically, clinically, and radiographically evaluate the healing sequelae of periodontally compromised extraction sockets grafted with Bio-Oss Collagen® at 3 and 6 months following tooth extraction in molar sites. The main question it aims to answer is:

Does healing time influence the histologic, clinical, and radiographic outcomes following socket grafting (alveolar ridge preservation) in periodontally compromised extraction sockets.

Researchers will compare a healing time of 3 months to a healing time of 6 months (conventional healing duration) to see if a shorter duration is viable for implant placement.

Participants will:

Take a cone-beam computed tomography (CBCT) scan to prepare for the surgical procedure.

Undergo tooth extraction and the extraction socket will be grafted with Bio-Oss Collagen® and a collagen membrane Bio-Gide® will be placed to stabilize the graft material.

Return at 2 weeks for suture removal and either 3- or 6-months post-extraction for implant placement.

Return at 2 weeks post-implant placement for suture removal, 3 months for prosthesis fabrication, 4 months for final prosthesis loading, and 1 year post-loading.

02

Conditions studied

  • Tooth Loss

Browse trials for

Keywords

  • ridge preservation
  • tooth extraction
03

In context

Tooth Loss

165 studies on the registry are indexed under Tooth Loss; 44 are open to participants now.

This study's planned enrollment of 42 is above the median of 30 across 120 interventional studies indexed under Tooth Loss.

Browse Tooth Loss studies →

Lead sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University is the lead sponsor of 164 studies on the registry; 73 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older
  • ASA (American Society of Anesthesia) status I or II
  • Need for molar extraction due to periodontal disease with or without chronic endodontic involvement, complying with the presentation of periodontitis stage III/IV
  • Radiographic evidence of a bone dehiscence on at least one socket wall, where the height of the horizontal (suprabony) component of the defect (alveolar bone crest - cement-enamel junction) is >50% of the corresponding root length as measured on CBCT scans prior to extraction (Ben Amara et al., 2021)
  • Radiographic evidence of at least 3 mm of residual bone wall height
  • Presence of at least one adjacent tooth to the extraction site
  • Treatment plan must include tooth replacement with an implant-supported fixed dental prosthesis

Exclusion criteria

Exclusion Criteria:

  • Extraction of multiple adjacent teeth
  • Acute infection associated with the tooth to be extracted or with adjacent teeth
  • Current smokers (>10 cigarettes per day)
  • Uncontrolled diabetes mellitus ( >7.0)
  • Any active oral or systemic acute infections
  • Currently receiving chemo- or radiotherapy or a history of radiotherapy in the head and neck area
  • Diseases or medications that may compromise normal wound healing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Implant placement 3 months after tooth extraction

    Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement 3 months after tooth extraction

    Procedure: Alveolar ridge preservation

  • Active comparator
    Implant placement 6 months after tooth extraction

    Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement 6 months after tooth extraction

    Procedure: Alveolar ridge preservation

Interventions

  • ProcedureAlveolar ridge preservation

    Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement at 2 different time intervals (3 and 6 months)

06

What researchers measure

Primary outcomes

  1. Percentage of vital bone via histomorphometric evaluation of bone core biopsies at 3 months

    Percentage of vital bone

    Time frame: 3 months

  2. Percentage of vital bone via histomorphometric evaluation of bone core biopsies at 6 months

    Percentage of vital bone

    Time frame: 6 months

Secondary outcomes

  1. Linear dimensional alterations of the alveolar ridge from the time of tooth extraction to the time of implant placement (3 months)

    Clinical and radiographic (via CBCT) assessment. The buccal-lingual ridge width at the time of the extraction will be measured clinically using a periodontal probe (UNC-15) and prior to implant placement (3-months). The same measurements will be performed radiographically through the CBCTs taken prior to tooth extraction and prior to implant placement, utilizing a CBCT viewer software. The linear vertical alterations will be used utilizing the same methods, using fiduciary anatomical landmarks. Superimposition of the digital files obtained from the intra-oral scanner will be utilized to verify these changes clinically.

    Time frame: 3 months

  2. Linear dimensional alterations of the alveolar ridge from the time of tooth extraction to the time of implant placement (6 months)

    Clinical and radiographic (via CBCT) assessment. The buccal-lingual ridge width at the time of the extraction will be measured clinically using a periodontal probe (UNC-15) and prior to implant placement (6-months). The same measurements will be performed radiographically through the CBCTs taken prior to tooth extraction and prior to implant placement, utilizing a CBCT viewer software. The linear vertical alterations will be used utilizing the same methods, using fiduciary anatomical landmarks. Superimposition of the digital files obtained from the intra-oral scanner will be utilized to verify these changes clinically.

    Time frame: 6 months

  3. Assessment of the mucosal healing of the extraction sites at 2 weeks using a wound healing index (1-3 scale rating)

    Wound Healing Index.1-3 scale rating: 1) Uneventful Healing, 2) Normal healing with moderate soft tissue inflammation, erythema but no suppuration and 3) poor wound healing with significant signs of clinical inflammation and/or suppuration

    Time frame: 2 weeks following tooth extraction and alveolar ridge preservation

  4. Assessment of the mucosal healing after implant placement at 2 weeks using a wound healing index (1-3 scale rating)

    Wound Healing Index.1-3 scale rating: 1) Uneventful Healing, 2) Normal healing with moderate soft tissue inflammation, erythema but no suppuration and 3) poor wound healing with significant signs of clinical inflammation and/or suppuration

    Time frame: 2 weeks after dental implant placement

  5. Patient reported outcomes (number of days of total or partially impaired activity) following tooth extraction

    Number of days of total or partially impaired activity

    Time frame: At the time of implant placement (3 or 6 months)

  6. Patient reported outcomes (number of days of total or partially impaired activity) following implant placement

    Number of days of total or partially impaired activity

    Time frame: 4 months post implant placement

  7. Patient reported outcomes (pain) 2 weeks following tooth extraction, using a Visual Analog Score for pain (0-100)

    Visual Analog Score for pain (0-100, with 0 representing no pain, and 100 very severe pain, described as "worse pain imaginable").

    Time frame: 2 weeks following tooth extraction and alveolar ridge preservation

  8. Patient reported outcomes (pain) 3 months following tooth extraction, using a Visual Analog Score for pain (0-100)

    Visual Analog Score for pain (0-100, with 0 representing no pain, and 100 very severe pain, described as "worse pain imaginable").

    Time frame: 3 months following tooth extraction and alveolar ridge preservation

  9. Patient reported outcomes (pain) 6 months following tooth extraction, using a Visual Analog Score for pain (0-100)

    Visual Analog Score for pain (0-100, with 0 representing no pain, and 100 very severe pain, described as "worse pain imaginable").

    Time frame: 6 months following tooth extraction and alveolar ridge preservation

  10. Patient reported outcomes (patient satisfaction), using a Visual Analog Scale (0-100)

    Patients will be asked to rate their satisfaction in terms of function, comfort and esthetics, using a Visual Analog Scale (0-100, with 0 meaning "not at satisfied at all" and 100 corresponding to "perfectly satisfied").

    Time frame: Up to 30 days post implant crown delivery

  11. Implant survival rate

    Percentage of implants still in the mouth

    Time frame: 1 year post implant loading

  12. Marginal bone level changes

    Measured in millimeters using standardized parallel technique intraoral radiographs

    Time frame: 1 year post implant loading

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Avila-Ortiz G, Elangovan S, Kramer KW, Blanchette D, Dawson DV. Effect of alveolar ridge preservation after tooth extraction: a systematic review and meta-analysis. J Dent Res. 2014 Oct;93(10):950-8. doi: 10.1177/0022034514541127. Epub 2014 Jun 25. PubMed 24966231 ↗
  • Dai A, Li HY, Kang S, Lin R, Huang JP, Mao F, Ding PH. Effect of alveolar ridge preservation at periodontally compromised molar extraction sockets: A retrospective cohort study. J Periodontol. 2025 Jan;96(1):9-20. doi: 10.1002/JPER.24-0064. Epub 2024 Jun 17. PubMed 38884702 ↗
  • Ben Amara H, Kim JJ, Kim HY, Lee J, Song HY, Koo KT. Is ridge preservation effective in the extraction sockets of periodontally compromised teeth? A randomized controlled trial. J Clin Periodontol. 2021 Mar;48(3):464-477. doi: 10.1111/jcpe.13412. Epub 2021 Jan 19. PubMed 33316099 ↗
  • Zellner JW, Allen HT, Kotsakis GA, Mealey BL. Wound healing after ridge preservation: A randomized controlled trial on short-term (4 months) versus long-term (12 months) histologic outcomes. J Periodontol. 2023 May;94(5):622-629. doi: 10.1002/JPER.22-0187. Epub 2023 Jan 10. PubMed 36527199 ↗
  • Couso-Queiruga E, Weber HA, Garaicoa-Pazmino C, Barwacz C, Kalleme M, Galindo-Moreno P, Avila-Ortiz G. Influence of healing time on the outcomes of alveolar ridge preservation using a collagenated bovine bone xenograft: A randomized clinical trial. J Clin Periodontol. 2023 Feb;50(2):132-146. doi: 10.1111/jcpe.13744. Epub 2022 Nov 18. PubMed 36345818 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06654141
Collaborators
Geistlich Pharma AG
Responsible party
Sponsor
First posted
Oct 23, 2024
Start date
Feb 6, 2025
Primary completion
Dec 2027 (estimated)
Completion
Dec 2029 (estimated)
Last update
Feb 19, 2025

Study contacts

Xinbo Yu, BDS
Contact
xinboyu@proton.me
86+23271699 ext. 6057

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion